register

News & Trends - MedTech & Diagnostics

Government assistance for the Australian MedTech sector

Health Industry Hub | May 4, 2020 |

MedTech News: The Medical Technology Association of Australia (MTAA) wrote to Minister Hunt recently outlining the very significant pressures facing the medical technology industry in the current environment and requesting a number of urgent measures to address the ongoing viability of Australia’s MedTech industry as the COVID-19 crisis continues.

The MTAA Board met with Health Minister Greg Hunt to discuss this and other matters, including the return to elective surgery and additional support measures for SMEs and Australian companies. 

Following this meeting and a period of intense discussions between MTAA and Minister Hunt and his office, a number of measures have been confirmed by the Minister in relation to PL reform.

MTAA has also been liaising with the Australian Tax Office (ATO) in order to seek clarity on the Jobkeeper provisions available to medtech companies, particular in relation to small companies where they are a local branch of a global company.

Register FREE and join 22,000+ industry professionals receiving the latest industry news and engaging content from Health Industry Hub, the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.

The ATO have clarified that, in determining whether a company must show a 30% or a 50% reduction in turnover, the global revenue of the global entity of which it is a part is included. If the global entity exceeds $1b, at least a 50% reduction must be demonstrated to qualify.

However, once the threshold is set, the turnover test itself is based on local GST revenue, not global revenue. Therefore, a small company which is a local branch of a global company exceeding $1b in revenue in total would still need to show that Australian turnover has fallen more than 50% to qualify for JobKeeper.

If global revenues were less than $1b, the fall in Australian turnover would only need to be 30% to qualify.

Customer engagement during COVID-19. Fill the gap of reduced field force activities. Health Industry Hub combines expertise in delivering digital health content with high engagement and 20+ years industry experience. By industry for industry. Contact us.


News & Trends - Pharmaceuticals

Roche's immunotherapy drug shows promising results for Australian patients with rare blood cancer

Roche’s immunotherapy drug shows promising results for Australian patients with rare blood cancer

Health Industry Hub | October 8, 2024 |

Pharma News: Roche’s immunotherapy drug has shown high response rates in patients with a rare form of blood cancer that […]

More


News & Trends - Pharmaceuticals

Government seals deal with industry for rare cancer therapy

Government seals deal with industry for rare cancer therapy

Health Industry Hub | October 8, 2024 |

Pharma News: Australian children and young adults diagnosed with high-risk neuroblastoma will continue to receive free access to a promising, […]

More


News & Trends - MedTech & Diagnostics

Abbott showcases leadless pacemaker system to local stakeholders

Abbott showcases leadless pacemaker system to local stakeholders

Health Industry Hub | October 8, 2024 |

MedTech & Diagnostics News: Leadless pacemakers are promising alternatives to transvenous pacing. Abbott hosted a stakeholder event at the recent […]

More


News & Trends - Pharmaceuticals

Australian scientists pivotal in new drug class from BMS

Australian scientists pivotal in new drug class from BMS

Health Industry Hub | October 8, 2024 |

Pharma News: The first new class of drug for schizophrenia in decades has been approved, offering a fresh approach by […]

More


This content is copyright protected. Please subscribe to gain access.